Tag | Content |
---|
EnhancerAtlas ID | HS182-19888 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr7:50472800-50473550 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
CDX2 | MA0465.1 | chr7:50472880-50472891 | TTTTATGGCCT | - | 6.02 |
|
| Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
SE_09412 | chr7:50468289-50485837 | CD14 | SE_10357 | chr7:50471995-50482114 | CD19_Primary | SE_10918 | chr7:50410368-50486056 | CD20 | SE_17327 | chr7:50471814-50475124 | CD4p_CD25-_CD45RAp_Naive | SE_18277 | chr7:50468855-50475066 | CD4p_CD25-_Il17-_PMAstim_Th | SE_22334 | chr7:50472529-50475098 | CD8_primiary | SE_61918 | chr7:50458805-50486267 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH07I050404 | chr7 | 50472234 | 50475870 |
|
Enhancer Sequence | CTTCTCACAT TCTCATTGGA AGCATATGGG TTCTCAAGGA ACGAAATCCC TTTGGCTGTT 60 CCCAAAACTC ATGTCTTTTC TTTTATGGCC TTACAACTCC AACACAGGGC TAGGCACAAA 120 AGACACACTC AAGGGATTGA GCAATTGGTA AAAGACCTGG AGGAAGTTTG ACAACCAAGA 180 CCGAAACTCC ACGTTCCTCC AAAGCCCAGG AAATCCTTCT GAAAACTTCT GGCCTTTTCT 240 CTGCACCAGA ACCCAGAACG GGCTGGCACA GTGTTGCTGT GCGGAGCTGA AGGCAAAATG 300 TTGCTGTTGC CTGCACAGAT CTGTCTTCTC TGCCTTTTTG CAAATCATCC GCCCCTAACT 360 TCCTCTAAGG AGGCAGAAAG GGATTCCCCG TGGCTCTTAG AATAGCAACC CTGCCCTCAG 420 CATCCTAGGC TCCCACTGGC TTCTCCTGCC ATTAAACAGG CCTGAGCAAA ACCATTCCCT 480 AGTTTTGAGT TGCCATGAGA CTCCCTCACC GACTCCAGCC TTGCCCCGGC TCCAGTGCCT 540 CCAATGATCT CCCAGGACTT TGTTTCCCAA ATGCAGCTTG TAATCATCTG AGTGGCTGTT 600 AAAAATGCAG CTTTCAGAAG CCTCCTCCTG AACATTCTGG AGCTGGAGGT CTGGACACAG 660 CCCACCCTCG AGGTGTGGGA CCAGCCACCA AGTCGTGCTA AGCAGACTCC CAGTCCATTC 720 CTCCTAGAGA CAGTTACAGC CTTGCCTCTC 750
|